Published in J Immunol on September 01, 1962
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
Common themes in microbial pathogenicity. Microbiol Rev (1989) 7.78
Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76
Electron microscopic studies on streptococci. I. M antigen. J Exp Med (1969) 6.77
M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun (1972) 6.29
Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol (1996) 6.28
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55
Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun (2001) 5.27
New approaches for the laboratory recognition of M types of group A streptococci. J Exp Med (1971) 4.42
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun (1995) 4.40
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci U S A (1991) 3.60
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
M proteins of group A streptococci. Bacteriol Rev (1974) 3.15
Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun (1991) 3.12
The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med (1970) 2.97
The multiple molecular structure of the M proteins of group A streptococci. Proc Natl Acad Sci U S A (1965) 2.92
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A (1987) 2.90
Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77
Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75
Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun (2002) 2.74
Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci U S A (2006) 2.71
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59
Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol (1997) 2.55
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis (1996) 2.51
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest (1998) 2.47
The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J Exp Med (1988) 2.42
Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol (2003) 2.38
Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35
Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol Rev (1966) 2.24
Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24
Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun (1988) 2.24
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev (1996) 2.20
Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18
Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun (1979) 2.17
Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med (1989) 2.15
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun (1991) 2.06
Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05
Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49. J Bacteriol (1989) 2.04
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION. J Exp Med (1965) 2.02
Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun (1998) 2.00
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol (2004) 1.95
Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes. Infect Immun (1995) 1.95
Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med (1966) 1.89
Differential recognition of surface proteins in Streptococcus pyogenes by two sortase gene homologs. J Bacteriol (2002) 1.88
Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A (1995) 1.86
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc Natl Acad Sci U S A (1998) 1.85
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
STREPTOCOCCAL M ANTIGEN LOCATION AND SYNTHESIS, STUDIED BY IMMUNOFLUORESCENCE. J Exp Med (1963) 1.79
Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun (1995) 1.78
Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci. J Bacteriol (1990) 1.78
Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71
Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun (1983) 1.70
Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. J Bacteriol (1995) 1.70
Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68
Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun (1997) 1.68
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Fluorescent amplified-fragment length polymorphism analysis of an outbreak of group A streptococcal invasive disease. J Clin Microbiol (1998) 1.66
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65
Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun (1991) 1.64
Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med (1988) 1.63
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62
Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis (2004) 1.62
Retracted Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun (2001) 1.61
M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest (1994) 1.60
Common protective antigens of group A streptococcal M proteins masked by fibrinogen. J Exp Med (1984) 1.59
A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. Infect Immun (1989) 1.58
IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine (2010) 1.57
Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1982) 1.53
Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun (1992) 1.53
Amide bonds assemble pili on the surface of bacilli. Proc Natl Acad Sci U S A (2008) 1.53
Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. J Exp Med (1990) 1.52
Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun (2002) 1.52
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol (2002) 1.51
Role of macrophages in host resistance to group A streptococci. Infect Immun (2004) 1.49
M protein mediates streptococcal adhesion to HEp-2 cells. Infect Immun (1994) 1.48
Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun (2000) 1.45
Comparison of the leader sequences of four group A streptococcal M protein genes. Nucleic Acids Res (1988) 1.44
Genetic instability of M protein and serum opacity factor of group A streptocci: evidence suggesting extrachromosomal control. Infect Immun (1975) 1.44
Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med (1986) 1.43
Two major classes in the M protein family in group A streptococci. Proc Natl Acad Sci U S A (1992) 1.42
THE LYSIS OF CELL WALLS OF GROUP A STREPTOCOCCI BY STREPTOMYCES ALBUS ENZYME TREATED WITH DIISOPROPYL FLUOROPHOSPHATE. CHARACTERISTICS OF THE LYTIC REACTION AND THE SOLUBLE CELL WALL FRAGMENTS. J Exp Med (1965) 1.42
Staphylococcal manipulation of host immune responses. Nat Rev Microbiol (2015) 1.42
A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40
Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains. J Exp Med (1955) 10.31
Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med (1957) 10.14
Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med (1952) 7.16
Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med (1959) 5.02
Preparation and properties of a protein (R antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other serological groups. J Exp Med (1952) 4.84
Occurrence of R antigen specific for Group A type 3 streptococci. J Exp Med (1958) 4.01
An epizootic in Swiss mice caused by a group A Streptococcus, newly designated type 50. Am J Hyg (1960) 1.54
PREVENTION OF STREPTOCOCCAL PHARYNGITIS AMONG MILITARY PERSONNEL AND THEIR CIVILIAN DEPENDENTS BY MASS PROPHYLAXIS. N Engl J Med (1964) 0.79
Bacteriological studies of cardiac tissues obtained at autopsy from eleven patients dying with rheumatic fever. Arthritis Rheum (1961) 0.75